Skip to search formSkip to main contentSkip to account menu

pitolisant

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Aim To assess the non-inferiority of pitolisant, a new compound for the relief of excessive daytime sleepiness (EDS) and… 
2020
2020
Methylphenidate, a central stimulant related to amphetamine indicated in attention deficit hyperactivity disorders and narcolepsy… 
2019
2019
Limited treatment options are available for patients with central hypersomnia, and many patients continue to have significant… 
2017
2017
▼Pitolisant (Wakix—Bioprojet Pharma) is a new treatment for adults with narcolepsy with or without cataplexy. It was licensed for… 
2016
2016
BackgroundPitolisant (BF2.649) is a nonimidazole histamine 3 receptor antagonist. In previous animal studies, it has been shown… 
2016
2016
The objective of the present study was to compare the effects of pitolisant on QTcF interval in a single ascending dose (SAD… 
2013
2013
A simple and sensitive LC-MS/MS method was developed and validated for the quantitation of pitolisant, an H3 receptor antagonist…